[1]张 芝,汤学超.心房分流器治疗心力衰竭机制及研究进展[J].介入放射学杂志,2023,32(06):612-616.
　ZHANG Zhi,TANG Xuechao..Mechanism of atrial shunt device for the treatment of heart failure and its research progress[J].journal interventional radiology,2023,32(06):612-616.
点击复制

心房分流器治疗心力衰竭机制及研究进展()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
32
期数:
2023年06
页码:
612-616
栏目:
综述
出版日期:
2023-06-28

文章信息/Info

Title:
Mechanism of atrial shunt device for the treatment of heart failure and its research progress
作者:
张 芝;  汤学超
Author(s):
ZHANG Zhi;  TANG Xuechao.
Department of Cardiology， Tai’an 88th Hospital of PLA， Tai’an， Shandong Province 271000， China
关键词:
【关键词】 心房分流器;  心力衰竭;  左心室射血分数;  器械治疗
文献标志码:
A
摘要:
【摘要】 心力衰竭（简称心衰）是各种心血管疾病终末期表现。心衰恶化是患者反复住院的主要原因。研究证实心衰恶化与死亡率间存在显著相关性。目前单纯药物治疗往往不足以改善心衰患者临床症状和体征，越来越多临床试验研究证实器械治疗可改善患者症状及预后。近年来国内外研究开发的具有独特机制的心房分流器主要有IASD、V-Wave、AFR及D-Shant等，临床应用研究证明，可通过直接降低左心房压力改善心衰患者呼吸困难症状，降低再住院率和病死率，未来可能成为治疗心衰新方法。本文就心房分流器治疗心衰机制及研究进展作一综述。

参考文献/References:

［1］ Tomasoni D，Adamo M，Anker MS，et al. Heart failure in the last year：progress and perspective［J］. ESC Heart Fail， 2020， 7： 3505- 3530.
［2］ Mozaffarian D，Benjamin EJ，Go AS，et al. Heart disease and stroke statistics- 2015 update： a report from the American Heart Association［J］. Circulation， 2015， 131： e29- 322.
［3］ Maggioni AP，Dahlstrom U，Filippatos G，et al. EURObservational Research Programme： regional differences and 1- year follow- up results of the Heart Failure Pilot Survey（ESC- HF Pilot）［J］. Eur J Heart Fail， 2013， 15： 808- 817.
［4］ Ahmed A，Allman RM，Fonarow GC，et al. Incident heart failure hospitalization and subsequent mortality in chronic heart failure： a propensity- matched study［J］. J Card Fail， 2008， 14： 211- 218.
［5］ Mcdonagh T，Metra M，Adamo M，et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure［J］. Eur Heart J， 2021， 42： 3599- 3726.
［6］ Freed BH，Shah SJ. Stepping out of the left ventricle’s shadow： time to focus on the left atrium in heart failure with preserved ejection fraction［J］. Circ Cardiovasc Imaging， 2017， 10： e006267.
［7］ Reddy Y，Obokata M，Wiley B， et al. The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction［J］. Eur Heart J， 2019， 40： 3721- 3730.
［8］ Ritzema J，Troughton R，Melton Ⅰ，et al. Physician- directed patient self- management of left atrial pressure in advanced chronic heart failure［J］. Circulation， 2010， 121： 1086- 1095.
［9］ Abudiab MM，Redfield MM，Melenovsky V，et al. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction［J］. Eur J Heart Fail， 2013， 15： 776- 785.
［10］ Borlaug B，Nishimura RA，Sorajja P，et al. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction［J］. Circ Heart Fail， 2010， 3： 588- 595.
［11］ Lauder L，Pereira TV，Degenhardt MC，et al. Feasibility and efficacy of transcatheter interatrial shunt devices for chronic heart failure： a systematic review and meta- analysis［J］. Eur J Heart Fail， 2021， 23： 1960- 1970.
［12］ Askey JM， Kahler JE. Longevity in extensive organic heart lesions： a case of Lutembacher’s syndrome in a man aged 72［J］. Ann Intern Med， 1950， 33： 1031- 1036.
［13］ Beyer J.Atrial septal defect： acute left heart failure after surgical closure［J］. Ann Thorac Surg， 1978， 25： 36- 43.
［14］ Aiyagari RM，Rocchini AP，Remenapp RT，et al. Decompression of the left atrium during extracorporeal membrane oxygenation using a transseptal cannula incorporated into the circuit［J］. Crit Care Med， 2006， 34： 2603- 2606.
［15］ Seib PM，Faulkner SC，Erickson CC，et al. Blade and balloon atrial septostomy for left heart decompression in patients with severe ventricular dysfunction on extracorporeal membrane oxygenation［J］. Catheter Cardiovasc Interv， 1999， 46： 179- 186.
［16］ Kaye D，Shah SJ，Borlaug B，et al. Effects of an interatrial shunt on rest and exercise hemodynamics： results of a computer simulation in heart failure［J］. J Card Fail， 2014， 20： 212- 221.
［17］ Stout KK，Daniels CJ，Aboulhosn JA，et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease： a report of the American college of cardiology/American heart association task force on clinical practice guidelines［J］. J Am Coll Cardiol， 2019， 73： e81- e192.
［18］ Hasenfuss G，Hayward C，Burkhoff D，et al. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction（REDUCE LAP- HF）： a multicentre， open- label， single- arm， phase 1 trial［J］. Lancet， 2016， 387： 1298- 1304.
［19］ Kaye DM，Hasenfub G，Neuzil P，et al. One- year outcomes after transcatheter insertion of an interatrial shunt device for the management of heart failure with preserved ejection fraction［J］. Circ Heart Fail， 2016， 9： e003662.
［20］ Feldman T，Mauri L，Kahwash R，et al. Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction（REDUCE LAP- HF I［reduce elevated left atrial pressure in patients with heart failure］）：a phase 2， randomized， sham- controlled trial［J］. Circulation， 2018， 137： 364- 375.
［21］ Shah SJ，Feldman T，Ricciardi MJ，et al. One- year safety and clinical outcomes of a transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction in the reduce elevated left atrial pressure in patients with heart failure（REDUCE LAP- HF I）trial： a randomized clinical trial［J］. JAMA Cardiol， 2018， 3： 968- 977.
［22］ Shah SJ，Borlaug BA，Chung ES，et al. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction （REDUCE LAP- HF II）： a randomised， multicentre， blinded， sham- controlled trial［J］. Lancet，2022，399：1130- 1140.
［23］ Del Trigo M，Bergeron S，Bernier M，et al. Unidirectional left- to- right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction： a safety and proof- of- principle cohort study［J］. Lancet， 2016， 387： 1290- 1297.
［24］ Rodes- Cabau J，Bernier M，Amat- Santos IJ，et al. Interatrial shunting for heart failure： early and late results from the first- in- human experience with the V- wave system［J］. JACC Cardiovasc Interv， 2018， 11： 2300- 2310.
［25］ Paitazoglou C，Bergmann MW，Ozdemir R，et al. One- year results of the first- in-man study investigating the atrial flow regulator for left atrial shunting in symptomatic heart failure patients： the PRELIEVE study［J］. Eur J Heart Fail， 2021， 23： 800- 810.
［26］ Bakhshaliyev N，Celikkalei， Enhos A， et al. Impact of atrial flow regulator（AFR） implantation on 12- month mortality in heart failure： insights from a single site in the PRELIEVE study［J］. Herz， 2022， 47：366- 373.
［27］ 尚小珂，张长东，陈 澍，等． D- Shant心房分流器的初步动物实验研究［J］． 中国介入心脏病学杂志， 2020， 28：337- 342．
［28］ 李 贺，王 斌，尚小珂，等． 国产D- Shant心房分流器临床应用及超声评估［J］． 中华超声影像学杂志， 2021， 30：180- 182．
［29］ 邵婷凯，郜俊清，刘宗军，等． 慢性心力衰竭经皮肾交感神经射频消融术临床疗效Meta分析［J］． 介入放射学杂志， 2022， 31：180- 184．
［30］ 汤学超，秦永文．经皮心室重建术——心力衰竭治疗新手段［J］．介入放射学杂志， 2016， 25：453- 455．
［31］ Müller D，Remppis A，Schauerte P，et al. Clinical effects of long- term cardiac contractility modulation（CCM） in subjects with heart failure caused by left ventricular systolic dysfunction［J］. Clin Res Cardiol， 2017， 106： 893- 904.

相似文献/References:

[1]朱天宇,朱政斌,丁风华,等.国产左心室隔离装置治疗左心室壁瘤动物实验研究[J].介入放射学杂志,2016,(09):803.
　ZHU Tian- yu,ZHU Zheng- bin,DING Feng- hua,et al.Domestic left ventricular partitioning device for the treatment of left ventricular aneurysm： an experimental study in animals[J].journal interventional radiology,2016,(06):803.
[2]杨 伟,刘宗军,郜俊清,等.慢性重度心力衰竭伴窄QRS波患者去肾交感神经术1年疗效 [J].介入放射学杂志,2018,27(06):500.
　YANG Wei,LIU Zongjun,GAO Junqing,et al.Renal sympathetic denervation for patients with chronic severe heart failure and concomitant narrow QRS complex： observation of one- year curative effect[J].journal interventional radiology,2018,27(06):500.
[3]杜兴祥,翁俊飞,肖群林,等.左右心室电极间距离指导心脏再同步化治疗临床效果和安全性[J].介入放射学杂志,2021,30(04):331.
　DU Xingxiang,WENG Junfei,XIAO Qunlin,et al.The clinical effect and safety of cardiac resynchronization therapy guided by the interlead distance between left and right ventricular electrodes [J].journal interventional radiology,2021,30(06):331.
[4]翁俊飞,董 薇,刘雷雷,等.左心室多位点起搏在非特异性室内传导阻滞伴低射血分数心力衰竭患者治疗中的应用[J].介入放射学杂志,2022,31(01):14.
　WENG Junfei,DONG Wei,LIU Leilei,et al.The application of left ventricular multipoint pacing in patients with heart failure complicated by nonspecific intraventricular block and reduced left ventricular ejection fraction[J].journal interventional radiology,2022,31(06):14.
[5]刘雷雷,董 薇,翁俊飞,等.3D打印技术指导心脏再同步化治疗中左右心室电极的定位1例[J].介入放射学杂志,2022,31(07):715.
　LIU Leilei,DONG Wei,WENG Junfei,et al.Application of 3D printing technology in guiding the positioning of right and left ventricular electrodes in performing cardiac resynchronization therapy： report of one case[J].journal interventional radiology,2022,31(06):715.
[6]梁玉佳,吴 强.联合应用多种技术指导左心室起搏电极植入部位的研究[J].介入放射学杂志,2023,32(08):825.
　LIANG Yujia,WU Qiang..Application of combination use of multiple techniques in guiding implantation site of left ventricular pacing electrode[J].journal interventional radiology,2023,32(06):825.

备注/Memo

备注/Memo:
（收稿日期：2022- 03- 21）
（本文编辑：边 佶）
更新日期/Last Update: 2023-06-26